期刊文献+

Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions 被引量:5

Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions
原文传递
导出
摘要 Background The safety and efficacy of drug-eluting stents (DES) implantation in unprotected left main (LM) bifurcation lesions has yet to be determined. The aim of the present report was to evaluate the long-term outcome following implantation of DES in unprotected LM bifurcation lesions.Methods We identified 70 consecutive patients treated with DES in unprotected LM bifurcation lesions from April 2003 to January 2005. Of them, 42 patients were treated with sirolimus-eluting stent (SES) and 28 patients were treated with paclitaxel-eluting stent (PES). Results Stents to the left anterior descending and to the circumflex were implanted in 62 patients. During 1-year follow-up, 3 (4.3%) patients died of cardiac causes. One of them had myocardial infarction and adjudicated as possibly due to stent thrombosis. Angiographic follow-up was available in 80% of patients. The per lesion restenosis rate was 13.4% in the entire cohort, of which 10.7% occurred in lesions treated with SES and 16.1% in those treated with PES (P=0.58). All restenosis was focal and occurred in the lesions treated with a stent with stent size to post-procedural reference vessel diameter ratio 〈1.0 (17.6% vs 0, P=0.04). The per patient target lesion revascularization rate at 1 year was 17.1%. One year survival free from major adverse cardiac events was 77.1%. Conclusions Treatment of LM bifurcation lesions using DES is a safe and feasible way with a low one-year mortality. The need for revascularization in 17% of patients demands for improvement. Background The safety and efficacy of drug-eluting stents (DES) implantation in unprotected left main (LM) bifurcation lesions has yet to be determined. The aim of the present report was to evaluate the long-term outcome following implantation of DES in unprotected LM bifurcation lesions.Methods We identified 70 consecutive patients treated with DES in unprotected LM bifurcation lesions from April 2003 to January 2005. Of them, 42 patients were treated with sirolimus-eluting stent (SES) and 28 patients were treated with paclitaxel-eluting stent (PES). Results Stents to the left anterior descending and to the circumflex were implanted in 62 patients. During 1-year follow-up, 3 (4.3%) patients died of cardiac causes. One of them had myocardial infarction and adjudicated as possibly due to stent thrombosis. Angiographic follow-up was available in 80% of patients. The per lesion restenosis rate was 13.4% in the entire cohort, of which 10.7% occurred in lesions treated with SES and 16.1% in those treated with PES (P=0.58). All restenosis was focal and occurred in the lesions treated with a stent with stent size to post-procedural reference vessel diameter ratio 〈1.0 (17.6% vs 0, P=0.04). The per patient target lesion revascularization rate at 1 year was 17.1%. One year survival free from major adverse cardiac events was 77.1%. Conclusions Treatment of LM bifurcation lesions using DES is a safe and feasible way with a low one-year mortality. The need for revascularization in 17% of patients demands for improvement.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第7期545-551,共7页 中华医学杂志(英文版)
关键词 STENTS REVASCULARIZATION RESTENOSIS THROMBOSIS stents revascularization restenosis thrombosis
  • 相关文献

参考文献10

  • 1Brueren BR,Ernst JM,Suttorp MJ,ten Berg JM,Rensing B J,Mast EG,et al.Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis:is it time to change the guidelines[].Heart.2003
  • 2Ajani AE,Waksman R,Cha DH,Gruberg L,Satler LF,Pichard AD,et al.The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation[].Journal of the American College of Cardiology.2002
  • 3Park,SJ,Hong,MK,Lee,CW,Kim,JJ,Song,JK,Kang,DH,Park,SW,Mintz,GS.Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance[].Journal of the American College of Cardiology.2001
  • 4Kelley,MP,Klugherz,BD,Hashemi,SM,Meneveau,NF,Johnston,JM,Matthai,WH,Banka,VS,Herrmann,HC,Hirshfeld,JW,Kimmel,SE,Kolansky,DM,Horwitz,PA,Schiele,F,Bassand,JL,Wilensky,RL.One-year clinical outcomes of protected and punprotected left main coronary artery stenting[].European Heart Journal.2003
  • 5Hu FB,Tamai H,Kosuga K,Kyo E,Hata T,Okada M,et al.Intravascular ultrasound-guided directional coronary atherectomy for unprotected left main coronary stenoses with distal bifurcation involvement[].The American Journal of Cardiology.2003
  • 6Takagi T,Stankovic G,Finci L.Results and long-term predictors ofadverse clinical events after elective percutaneous interventions on un-protected left main coronary artery[].Circulation.2002
  • 7Park SJ,Lee CW,Kim YH,et al.Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing[].The American Journal of Cardiology.2002
  • 8Colombo,A,Moses,JW,Morice,MC,Ludwig,J,Jr,Holmes,DR,Spanos,V,Louvard,Y,Desmedt,B,Di Mario,C,Leon,MB.Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions[].Circulation.2004
  • 9Black,A,Cortina,R,Bossi,I,Choussat,R,Fajadet,J,Marco,J.Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection[].Journal of the American College of Cardiology.2001
  • 10Silvestri,M,Barragan,P,Sainsous,J,Bayet,G,Simeoni,JB,Roquebert,PO,Macaluso,G,Bouvier,JL,Comet,B.Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures[].Journal of the American College of Cardiology.2000

同被引文献9

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部